Ameriprise’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $6.02M | Buy |
|
|||||
|
2025
Q1 | $1.31M | Buy |
|
|||||
|
2024
Q4 | $732K | Buy |
|
|||||
|
2024
Q3 | $470K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $353K | Sell |
|
|||||
|
2023
Q4 | $418K | Sell |
|
|||||
|
2023
Q3 | $584K | Sell |
|
|||||
|
2023
Q2 | $1.85M | Sell |
|
|||||
|
2023
Q1 | $1.82M | Buy |
|
|||||
|
2022
Q4 | $302K | Sell |
|
|||||
|
2022
Q3 | $197K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $13.8M | Buy |
|
|||||
|
2021
Q1 | $18.6M | Sell |
|
|||||
|
2020
Q4 | $19.8M | Buy |
|